Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Psyllium husks are the outer coverings of seeds from the Plantago ovata plant, primarily grown in India. They are a natural source of soluble fiber and act as a bulk-forming laxative. When ingested with water, psyllium absorbs liquid in the intestines, swells, and forms a gelatinous mass that increases stool bulk and moisture. This stimulates intestinal motility through mechanical stretching of the gut wall, making stools easier to pass and relieving constipation[1][2][4][5]. Psyllium is also partially fermentable by colonic bacteria, producing short-chain fatty acids beneficial for colon health[5]. Beyond its primary use for constipation, it can help manage diarrhea (by absorbing excess water), lower LDL cholesterol when used with a low-cholesterol diet[2][3][6], improve glycemic control in diabetes[7], relieve symptoms of irritable bowel syndrome (IBS), hemorrhoids, and may aid weight management by promoting satiety[3][6][7]. It is available over-the-counter in various formulations including powders and capsules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on psyllium husks.